Adaptation Of Chemotherapy To The Decline Tumor Markers In Patients With Poor Prognosis Nonseminomatous Germ Cell Tumors:Real-World French Experience.

Marion Rolland,Sara Faouzi,Leonor Chaltiel,Clement Dumont,Lionnel Geoffrois,Marine Gross-Goupil,Brigitte Laguerre,Mathilde Guerin,Ludovic Doucet,Guilhem Roubaud, Magalie Tardy,Stephane Oudard, Aude Flechon,Diego Tosi,Hakim Mahammedi,Christine Chevreau,Damien Pouessel,Karim Fizazi

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览10

暂无评分

摘要

385Background: Personalized chemotherapy based on tumor marker decline is the new standard in poor prognosis germ-cell tumor in Europe since 2014 (GETUG 13, Lancet, Fizazi et al). The purpose of th...

查看译文

关键词

Germ cell tumors,Tumor marker,Chemotherapy,Oncology,Medicine,In patient,Internal medicine,Poor prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要